Published • loading... • Updated
A Johns Hopkins study found that just 36% of rural Medicare patients with advanced lung cancer received testing that can guide targeted treatment
Summary by Medical Daily
1 Articles
1 Articles
A Johns Hopkins study found that just 36% of rural Medicare patients with advanced lung cancer received testing that can guide targeted treatment
A Johns Hopkins study found that only 36% of rural Medicare patients with advanced non-small cell lung cancer received molecular testing, which can guide targeted treatment.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
